No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
305 |
4. Check minimum number of eventsNone |
305 |
5. Include endpointsNone |
305 |
6. Filter based on genotype QC (FinnGen only) |
305 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF7
Similar endpoints
↥List of similar endpoints to
Right ventricular outflow tract obstruction
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of heart and great arteries
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4198 | 2225 | 1962 |
| Only index persons | 2655 | 1420 | 1235 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.06 | 0.05 |
| Only index persons | 0.05 | 0.05 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 0.66 | 0.59 | 0.58 |
| Only index persons | 3.15 | 3.48 | 2.76 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 305 | 162 | 143 |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | 0.06 |
| Median age at first event (years) | 5.09 | 6.79 | 3.17 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 287
- Matched controls
- 2868
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q22.1
ICD-10 Finland
Congenital pulmonary valve stenosis
+∞
190.5
161
*
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
36.5
86.7
113
50
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
21.2
85.9
137
118
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
13.5
80.7
171
281
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
24.4
75.2
111
72
201
Kela drug reimbursment
Chronic cardiac insufficiency
46.9
74.8
91
28
XF400
NOMESCO Finland
ECG with 12 standard connections
10.6
66.7
160
304
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
39.1
61.7
78
27
C03DA01
ATC
spironolactone; oral
20.6
57.7
89
61
XF404
NOMESCO Finland
Ambulatory ECG
15.3
56.2
99
95
C03CA01
ATC
furosemide; systemic
12.9
54.3
105
123
XF402
NOMESCO Finland
ECG with work load test
18.4
51.7
83
62
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
55.5
49.5
58
13
31
HP
Congenital heart failure surgery
146.9
47.4
49
*
B01AA03
ATC
warfarin; systemic
15.7
47.3
81
70
I37.0
ICD-10 Finland
Pulmonary valve stenosis
+∞
47.2
44
*
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
49.2
46.8
56
14
GD1AA
NOMESCO Finland
Thorax X-ray examination
6.4
46.4
176
569
ZXE20
NOMESCO Finland
More than three and less than five hours
9.0
44.9
107
177
FM2CE
NOMESCO Finland
NA
13.3
44.8
83
85
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
10.6
43.2
91
120
61
HP
Catheterization and pressure measurement of the left side of the heart
90.5
42.3
46
6
Q25.6
ICD-10 Finland
Stenosis of pulmonary artery
+∞
41.7
39
*
C01AA05
ATC
digoxin; systemic
33.8
40.8
53
19
Z2221
NOMESCO Finland
Medical doctor
5.5
38.8
158
520
Q21.09
ICD-10 Finland
Ventricular septal defect NOS
48.1
37.5
45
11
Q22.0
ICD-10 Finland
Pulmonary valve atresia
+∞
37.3
35
*
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
51.6
37.1
44
10
ZXD10
NOMESCO Finland
Scheduled procedure
5.1
37.0
179
699
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
112.3
36.7
39
*
TPH07
NOMESCO Finland
Cathetrisation of artery
7.9
35.9
91
159
62
HP
Catheterization and pressure measurement of the right side of the heart
136.5
34.5
36
*
ZXE10
NOMESCO Finland
More than one and less than three hours
4.8
33.6
162
610
7460C
ICD-9 Finland
Other congenital anomalies of heart, Anomalies of pulmonary valve[VITIUM VALVULAE PULMONALIS CONGENITA CUM STENOSIS]
+∞
32.9
31
*
I37.1
ICD-10 Finland
Pulmonary valve insufficiency
127.9
32.4
34
*
Q21.10
ICD-10 Finland
Persistent ostium secundum
17.4
32.0
51
35
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
6.4
31.8
95
205
WX408
NOMESCO Finland
General anesthesy, balanced
4.7
31.7
151
552
ZXE30
NOMESCO Finland
More than five and less than seven hours
9.6
30.1
65
85
Q21.08
ICD-10 Finland
Other specifed ventricular septal defect
17.2
30.0
48
33
Q21.30
ICD-10 Finland
Tetralogy of Fallot
89.7
29.4
32
*
Q20.3
ICD-10 Finland
Discordant ventriculoarterial connection
115.3
29.3
31
*
XF622
NOMESCO Finland
Measurement of minute volume of heart
46.3
27.4
33
8
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
9.7
27.3
58
73
Q20.48
ICD-10 Finland
Single ventricle
107.0
27.2
29
*
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
29.2
26.9
36
14
Q20.1
ICD-10 Finland
Double outlet right ventricle
+∞
26.5
25
*
FM1CG
NOMESCO Finland
Extensive examination of hear with high intensity magnet
37.0
26.2
33
10
Q24.3
ICD-10 Finland
Pulmonary infundibular stenosis
+∞
25.4
24
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
7.8
24.0
58
90
XF600
NOMESCO Finland
Bloodpressure measurement
5.7
23.4
74
165
5255
FHL
Deep hypothermia (<20 °) with cardiopulmonary resuscitation
+∞
23.2
22
*
FXA10
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure
49.4
22.8
27
6
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.9
22.8
122
458
Z98.8
ICD-10 Finland
Other specified postsurgical states
17.9
22.5
35
22
Z3231
NOMESCO Finland
Registered nurse
3.6
22.3
146
646
74663
ICD-8 Finland
Congenital anomalies of heart, Stenosis valvulae pulmonalis
+∞
22.2
21
*
WX882
NOMESCO Finland
High dependency care
5.6
21.4
68
151
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
32.9
21.0
27
9
FBE32
NOMESCO Finland
Percutaneous transluminal angioplasty of pulmonary artery
118.6
20.9
22
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
7.0
20.5
53
90
R4110
NOMESCO Finland
Physiotherapy
3.6
20.2
121
487
ZXD05
NOMESCO Finland
Urgent procedure
3.5
20.2
124
510
Q22.2
ICD-10 Finland
Congenital pulmonary valve insufficiency
+∞
20.0
19
*
FJF20
NOMESCO Finland
Replacement of pulmonary valve using homograft
112.8
19.8
21
*
C01BD01
ATC
amiodarone; systemic
49.7
19.5
23
5
XFE00
NOMESCO Finland
Epicardial ultrasonography
22.0
19.5
28
14
ZXE00
NOMESCO Finland
One hour or less
3.2
19.4
163
838
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
18.8
19.1
29
17
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
13.6
19.1
33
27
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
75.0
19.0
21
*
FBJ10
NOMESCO Finland
Anastomosis to pulmonary artery from subclavian artery with interposition graft
202.5
18.8
19
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
11.5
18.2
34
33
Q22.41
ICD-10 Finland
Tricuspid atresia
+∞
17.9
17
*
FN1BB
NOMESCO Finland
Contrast angiography of heart and/or coronary arteries after bypass surgery
17.4
17.4
27
17
FBE10
NOMESCO Finland
Expansion or reconstruction of pulmonary artery using patch
67.5
16.9
19
*
Q21.32
ICD-10 Finland
Pulmonary atresia with Fallot ventricular septal defect
+∞
16.8
16
*
I37.2
ICD-10 Finland
Pulmonary valve stenosis with insufficiency
+∞
16.8
16
*
Q87.14
ICD-10 Finland
Noonan's syndrome
179.8
16.7
17
*
WX872
NOMESCO Finland
Intensive care
11.8
15.9
29
27
G04BE03
ATC
sildenafil; oral
23.7
15.8
22
10
Q25.78
ICD-10 Finland
Other congenital malformations of pulmonary artery
90.0
15.7
17
*
FJD20
NOMESCO Finland
Bypass of pulmonary valve with ventriculopulmonary prosthesis or homograft
168.6
15.6
16
*
I48
ICD-10 Finland
Atrial fibrillation and flutter
6.9
15.4
39
64
TFP20
NOMESCO Finland
Cardiodefibrillation
11.0
15.3
29
29
207
Kela drug reimbursment
Chronic arrhythmias
8.0
15.3
35
49
FDF05
NOMESCO Finland
Percutaneous transluminal occlusion of aorto-pulmonary collaterals
47.7
15.2
18
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.5
15.1
82
297
FBE35
NOMESCO Finland
Percutaneous transluminal angioplasty of pulmonary artery with insertion of stent
59.9
14.9
17
*
Q25.0
ICD-10 Finland
Patent ductus arteriosus
15.3
14.8
24
17
Z3226
NOMESCO Finland
Physiotherapist
3.2
14.8
96
393
WX892
NOMESCO Finland
Monitored bed care
4.7
14.8
53
132
1EA01
NOMESCO Finland
NA
+∞
14.7
14
*
FJF10
NOMESCO Finland
Replacement of pulmonary valve using biological prosthesis
+∞
14.7
14
*
XQ903
NOMESCO Finland
Production of other scan or drawing
157.5
14.6
15
*
FN1CC
NOMESCO Finland
Very extensive angiography of heart and/or coronary arteries
31.8
14.0
18
6
Q20.40
ICD-10 Finland
Double inlet left ventricle
+∞
13.6
13
*
74734
ICD-8 Finland
Other congenital anomalies of circulatory system, Stenosis, hypoplasia sive aplasia arteriae pulmonalis
+∞
13.6
13
*
ZX120
NOMESCO Finland
Intravenous
4.4
13.2
50
131
C07AA07
ATC
sotalol; systemic
17.8
13.2
20
12
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
13.1
12.8
22
18
Q21.19
ICD-10 Finland
Atrial septal defect NOS
33.7
12.7
16
5
7AX01
NOMESCO Finland
NA
21.2
12.6
18
9
Q22.3
ICD-10 Finland
Other congenital malformations of pulmonary valve
+∞
12.6
12
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
7.0
12.6
31
49
WX704
NOMESCO Finland
Intubation
5.3
12.5
39
83
Q25.41
ICD-10 Finland
Persistent right-sided aortic arch
39.4
12.3
15
*
ZX199
NOMESCO Finland
Other rote
14.2
12.1
20
15
FJE42
NOMESCO Finland
Percutaneous transluminal expansion of pulmonary valve
48.8
12.0
14
*
RS224
NOMESCO Finland
NA
10.3
12.0
23
24
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.2
11.8
68
251
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
6.3
11.7
31
54
Q22.40
ICD-10 Finland
Congenital tricuspid stenosis
+∞
11.5
11
*
7468X
ICD-9 Finland
Other congenital anomalies of heart, Other specified anomalies of heart[MUU SYDÄMEN EPÄMUODOSTUMA]
+∞
11.5
11
*
5253
FHL
Cardiac lung machine
124.7
11.5
12
*
I44.2
ICD-10 Finland
Atrioventricular block, complete
21.1
11.3
16
8
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.5
11.1
105
530
FPF20
NOMESCO Finland
Implantation of epicardial pacemaker with atrial and ventricular electrodes
45.1
11.0
13
*
C09AA02
ATC
enalapril; systemic
4.5
11.0
39
96
Q21.0
ICD-10 Finland
Ventricular septal defect
29.3
10.8
14
5
Q23.4
ICD-10 Finland
Hypoplastic left heart syndrome
29.3
10.8
14
5
FAE10
NOMESCO Finland
Bidirectional anastomosis between superior vena cava and pulmonary artery
113.9
10.5
11
*
Q24.0
ICD-10 Finland
Dextrocardia
113.9
10.5
11
*
FM1BD
NOMESCO Finland
Extensive CT of heart
113.9
10.5
11
*
Q22.6
ICD-10 Finland
Hypoplastic right heart syndrome
+∞
10.5
10
*
Q21.3
ICD-10 Finland
Tetralogy of Fallot
+∞
10.5
10
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.2
10.4
58
209
FAE00
NOMESCO Finland
Anastomosis to pulmonary artery from superior vena cava
33.9
10.4
13
*
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
7.7
10.2
23
32
I47.1
ICD-10 Finland
Supraventricular tachycardia
6.7
10.1
25
40
602
Kela drug reimbursment
Children's severe malnutrition
5.4
10.1
30
61
Z01.8
ICD-10 Finland
Other specified special examinations
2.8
9.9
74
320
FXA20
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia and circulatory arrest at concurrent surgical procedure
31.1
9.5
12
*
FHB50
NOMESCO Finland
Transatrial closure of VSD using patch
22.6
9.4
13
6
7461A
ICD-9 Finland
Other congenital anomalies of heart, Tricuspid atresia and stenosis, congenital[VITIUM VALVULAE TRICUSPIDALIS CONGENITUM CUM ATRESI]
+∞
9.4
9
*
FAE30
NOMESCO Finland
Total cavo-pulmonary connection using fenestrated patch
+∞
9.4
9
*
FBA96
NOMESCO Finland
Other suture or repair of pulmonary artery
+∞
9.4
9
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
10.5
9.1
17
17
C07AB07
ATC
bisoprolol; oral
2.7
9.0
69
303
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
5.4
8.9
26
52
FFC22
NOMESCO Finland
Percutaneous transluminal closure of ostium secundum type ASD
14.6
8.8
14
10
3A077
NOMESCO Finland
NA
51.5
8.7
10
*
Q21.11
ICD-10 Finland
Paten or persistent foramen ovale
8.6
8.7
18
22
RD210
NOMESCO Finland
NA
4.1
8.6
33
88
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
28.4
8.5
11
*
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
28.4
8.5
11
*
XF620
NOMESCO Finland
Examination of circulation with color method
92.6
8.5
9
*
7452A
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Tetralogy of Fallot[TETRALOGIA FALLOT]
+∞
8.4
8
*
Q21.18
ICD-10 Finland
Other spedified atrial septal defect
+∞
8.4
8
*
Q21.31
ICD-10 Finland
Tetralogy of Fallot and double outlet right ventricle
+∞
8.4
8
*
Q25.5
ICD-10 Finland
Atresia of pulmonary artery
+∞
8.4
8
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
8.4
63
273
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
5.2
8.3
25
52
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
17.8
8.1
12
7
FDA00
NOMESCO Finland
Aortoplasty and aorto-pulmonary shunt for HLHS
22.8
8.1
11
5
R07.4
ICD-10 Finland
Chest pain, unspecified
2.6
7.9
59
255
WX002
NOMESCO Finland
Sedation and analgesia
2.9
7.9
50
196
324
NOMESCO Finland
NA
46.2
7.8
9
*
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
46.2
7.8
9
*
FHE30
NOMESCO Finland
Repair of tetralogy of Fallot with transannular patch
46.2
7.8
9
*
WX402
NOMESCO Finland
General anaesthesia
2.3
7.7
83
432
Q25.1
ICD-10 Finland
Coarctation of aorta
10.4
7.6
14
14
FJD96
NOMESCO Finland
Other operation on right ventricle outlet for congenital or acquired obstruction
82.0
7.4
8
*
AEX
HP
Other pulmonary or pulmonary artery valve procedure
82.0
7.4
8
*
Q20.8
ICD-10 Finland
Other congenital malformations of cardiac chambers and connections
82.0
7.4
8
*
Q24.9
ICD-10 Finland
Congenital malformation of heart, unspecified
82.0
7.4
8
*
Q23.0
ICD-10 Finland
Congenital stenosis of aortic valve
13.8
7.4
12
9
5504
FHL
Subclavian pulmonary anastomosis (Blalock)
+∞
7.3
7
*
7451B
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Transposition of great vessels[DOUBLE OUTLET RIGHT VENTRICLE]
+∞
7.3
7
*
7460B
ICD-9 Finland
Other congenital anomalies of heart, Anomalies of pulmonary valve[VITIUM VALVULAE PULMONALIS CONGENITUM CUM ATRESIA]
+∞
7.3
7
*
FBJ00
NOMESCO Finland
Anastomosis to pulmonary artery from subclavian artery
+∞
7.3
7
*
Q22.8
ICD-10 Finland
Other congenital malformations of tricuspid valve
+∞
7.3
7
*
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
3.5
7.2
33
103
Q24.4
ICD-10 Finland
Congenital subaortic stenosis
30.8
7.2
9
*
FEB10
NOMESCO Finland
Decompression and drainage of pericardium
20.6
7.2
10
5
I49.5
ICD-10 Finland
Sick sinus syndrome
12.4
7.1
12
10
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
9.1
7.1
14
16
ZX108
NOMESCO Finland
Inhalation
9.1
7.1
14
16
Z2446
NOMESCO Finland
Social worker
2.5
7.0
58
262
B34.9
ICD-10 Finland
Viral infection, unspecified
3.6
7.0
31
94
I47.2
ICD-10 Finland
Ventricular tachycardia
14.2
6.9
11
8
Z94.1
ICD-10 Finland
Heart transplant status
14.2
6.9
11
8
I50.9
ICD-10 Finland
Heart failure, unspecified
5.2
6.8
20
41
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
41.0
6.8
8
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
6.8
64
313
Q21.21
ICD-10 Finland
Atrioventricular duct
23.1
6.7
9
*
Q26.1
ICD-10 Finland
Persistent left superior vena cava
23.1
6.7
9
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.9
6.5
38
141
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
3.8
6.5
26
73
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
6.5
77
416
7455A
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ostium secundum type atrial septal defect
71.3
6.4
7
*
FFK20
NOMESCO Finland
Atrio-pulmonary anastomosis
71.3
6.4
7
*
FWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels
71.3
6.4
7
*
FM1CD
NOMESCO Finland
Very extensive CT of heart
71.3
6.4
7
*
Q20.5
ICD-10 Finland
Discordant atrioventricular connection
71.3
6.4
7
*
I28.8
ICD-10 Finland
Other specified diseases of pulmonary vessels
71.3
6.4
7
*
ZXA00
NOMESCO Finland
Right side
2.4
6.4
57
268
UGC02
NOMESCO Finland
Rigid bronchoscopy
8.4
6.4
13
16
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.8
6.4
26
74
7505
FHL
Funicular lysis and orchidopexy
18.5
6.3
9
5
R62.0
ICD-10 Finland
Delayed milestone
3.5
6.3
28
86
74642
ICD-8 Finland
Congenital anomalies of heart, Defectus septi atriorum, ostium secundum
+∞
6.3
6
*
5233
FHL
Right ventricular bypass surgery (Fontan et al.)
+∞
6.3
6
*
FBE00
NOMESCO Finland
Expansion of pulmonary artery
+∞
6.3
6
*
FBE20
NOMESCO Finland
Reconstruction of pulmonary artery using tube graft
+∞
6.3
6
*
5239
FHL
Other measure in this category
+∞
6.3
6
*
7468B
ICD-9 Finland
Other congenital anomalies of heart, Other specified anomalies of heart[STENOSIS PULMONALIS INFUNDIBULARIS]
+∞
6.3
6
*
Q24.8
ICD-10 Finland
Other specified congenital malformations of heart
27.3
6.3
8
*
Q23.3
ICD-10 Finland
Congenital mitral insufficiency
27.3
6.3
8
*
B01AB05
ATC
enoxaparin; parenteral
2.5
6.1
48
212
I35.0
ICD-10 Finland
Aortic (valve) stenosis
12.9
6.1
10
8
205
Kela drug reimbursment
Chronic hypertension
3.0
6.1
34
121
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
3.1
6.1
32
112
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
133
99
23.11
152.57
7.4
4.7
ng/l
180.4
207.3
0.18
127
87
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
201
300
17.82
149.63
9.4
5.1
ng/l
736.6
904.6
0.51
195
245
(3032080) INR in Blood by Coagulation assay
176
560
6.09
55.27
13.1
6.1
inr
1.5
1.1
2.59
32
178
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
58
55
12.80
54.97
3.6
5.9
%
78.6
99.0
4.00
58
55
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
117
317
5.37
42.54
7.9
3.0
ng/l
3028.9
1254.0
0.89
102
184
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
148
499
4.83
40.83
3.8
3.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
47
52
10.51
39.69
16.9
23.1
u/ml
0.3
0.4
1.11
31
33
(3033658) Prothrombin time (PT) actual/Normal
158
589
4.50
37.57
11.0
7.4
%
71.5
89.4
15.72
158
583
(3044640) Blood type and Crossmatch panel - Blood
156
616
4.15
33.40
4.0
3.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
42
57
8.39
30.05
1.6
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
116
423
3.82
26.84
4.5
4.4
mg/l
1.7
1.9
0.16
84
306
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
185
938
3.48
25.05
4.8
4.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
44
77
6.51
24.92
24.5
23.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
82
256
4.02
23.40
2.7
2.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
87
291
3.79
22.40
4.7
3.0
%
22.5
22.7
0.04
82
266
(3044889) 12 lead EKG panel
202
1152
3.25
21.13
5.8
2.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
170
919
2.93
18.84
11.5
7.7
umol/l
19.1
22.0
0.62
163
863
(3023368) Bacteria identified in Blood by Culture
101
418
3.12
18.09
5.9
4.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
53
146
4.19
17.67
23.0
15.2
mmol/l
0.5
0.4
0.06
48
120
(3000494) Fungus identified in Specimen by Culture
64
215
3.50
15.97
1.8
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
93
404
2.88
14.91
18.9
11.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
75
289
3.12
14.90
2.7
1.9
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
16
15
11.20
14.76
2.8
7.3
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
19
23
8.74
14.66
1.3
2.1
%
141.2
129.0
0.34
19
23
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
40
104
4.28
14.30
27.7
14.1
%
0.6
0.8
1.36
40
104
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
119
598
2.63
14.26
3.4
3.3
mg/l
3.2
2.7
0.73
109
521
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
16
16
10.50
14.14
2.8
6.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
61
214
3.31
14.12
2.7
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
61
214
3.31
14.12
2.5
1.8
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
39
103
4.20
13.64
27.9
14.3
%
1.1
1.3
1.70
39
103
(40758558) Short blood count panel - Blood
136
762
2.42
12.58
7.6
9.3
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
20
31
6.84
12.53
1.3
2.0
%
113.2
120.9
0.20
20
31
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
96
461
2.58
12.36
20.1
14.2
mmol/l
25.3
24.9
0.82
96
461
(3024928) Oxygen saturation in Venous blood
26
55
5.08
11.89
6.1
18.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
80
366
2.61
11.26
16.8
9.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
161
1013
2.25
10.91
9.2
9.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
95
481
2.42
10.72
4.8
2.9
ng/l
34.6
19.2
0.74
60
233
(3013826) Glucose [Moles/volume] in Serum or Plasma
189
1279
2.26
10.60
14.2
7.2
mmol/l
5.8
6.2
3.43
183
1182
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
85
414
2.46
10.41
17.3
9.2
mmol/l
2.0
1.0
3.54
72
308
(3019550) Sodium [Moles/volume] in Serum or Plasma
279
2271
3.78
10.38
30.2
12.7
mmol/l
139.3
139.5
1.51
279
2202
(3022096) Basophils/100 leukocytes in Blood
190
1296
2.24
10.35
9.5
9.4
%
0.5
0.7
2.70
182
1237
(3006504) Eosinophils/100 leukocytes in Blood
193
1328
2.24
10.24
9.5
9.3
%
3.0
3.1
0.33
184
1265
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
11
10
11.38
10.22
1.5
1.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
167
1090
2.18
10.06
20.9
11.4
mmol/l
1.2
1.2
2.37
159
982
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
85
421
2.41
9.99
17.5
9.2
kpa
5.1
5.1
0.51
85
398
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
158
1014
2.16
9.88
24.0
12.0
mmol/l
1.2
1.2
3.88
153
959
(3019069) Monocytes/100 leukocytes in Blood
193
1340
2.21
9.85
9.7
9.4
%
9.2
8.2
5.28
185
1284
(3002030) Lymphocytes/100 leukocytes in Blood
198
1393
2.21
9.72
9.4
9.1
%
27.2
33.9
13.00
190
1338
(3002032) Base excess in Venous blood by calculation
87
442
2.36
9.61
9.1
10.3
mmol/l
1.6
1.0
1.26
75
348
(3013512) EKG study
76
369
2.41
9.27
5.8
3.0
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
193
1367
2.13
9.00
9.4
9.0
%
57.9
51.2
11.84
185
1315
(3015235) Bicarbonate [Moles/volume] in Capillary blood
27
74
3.91
8.94
9.4
10.5
mmol/l
22.1
23.3
1.16
27
63
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
28
79
3.80
8.91
2.1
2.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
193
1381
2.09
8.58
9.9
9.1
e9/l
0.0
0.0
0.68
177
1163
(3013115) Eosinophils [#/volume] in Blood
197
1421
2.10
8.56
10.4
9.9
e9/l
0.2
0.2
0.59
180
1222
(3019230) Fractional oxyhemoglobin in Venous blood
21
49
4.53
8.54
6.3
19.0
%
70.7
73.3
0.29
21
49
(3001604) Monocytes [#/volume] in Blood
192
1381
2.06
8.30
9.9
9.1
e9/l
0.6
0.6
1.38
176
1165
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
13
9
15.02
8.27
2.4
2.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
195
1426
2.02
7.85
9.9
9.1
e9/l
1.7
2.3
13.10
181
1237
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
27
83
3.47
7.58
2.1
2.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
199
1482
1.99
7.41
10.2
6.2
u/l
99.6
102.4
0.21
194
1399
(3007853) Bacteria identified in Skin by Aerobe culture
62
302
2.32
7.39
2.1
1.8
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
202
1521
1.98
7.18
11.3
11.5
e9/l
3.7
3.7
0.09
185
1290
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
20
52
4.05
7.10
2.0
1.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
289
2528
3.90
7.06
20.5
9.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
22
62
3.75
7.01
2.0
1.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
17
40
4.44
6.84
4.9
22.7
%
12.7
11.7
0.54
17
40
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
49
4.07
6.82
1.8
1.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
164
1171
1.87
6.64
4.3
3.3
ug/l
89.9
66.8
1.18
159
1108
(3002256) Pathology report gross observation
43
187
2.51
6.54
1.5
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
35
4.46
6.09
1.7
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
12
23
5.39
6.06
4.2
2.5
—
—
—
0
0
(44790049)
20
59
3.56
5.97
2.2
2.2
—
—
—
0
0
(44806118)
20
59
3.56
5.97
2.2
2.2
—
—
—
0
0
(44790047)
20
59
3.56
5.97
2.2
2.2
—
—
—
0
0
(44790048)
20
59
3.56
5.97
2.2
2.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
211
1662
1.88
5.96
17.4
8.1
ml/min/173m2
100.3
98.8
0.33
165
1229
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
20
60
3.50
5.83
1.2
1.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
87
527
1.91
5.73
3.1
2.9
u/l
54.2
60.5
0.74
82
491
(3052851) Hemolysis interference index of Serum or Plasma
20
62
3.38
5.55
2.0
2.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
19
57
3.49
5.54
2.1
3.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
16
43
3.87
5.44
6.2
7.4
—
—
—
0
0
(4268621)
13
30
4.48
5.35
2.2
2.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
124
854
1.76
5.32
4.1
4.8
e6/l
13.5
39.7
1.83
89
556
(3051611) Lipemic interference index of Serum or Plasma
14
35
4.14
5.23
1.9
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
31
4.34
5.14
1.3
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
75
447
1.90
5.13
3.2
3.2
mosm/kgh2o
558.9
583.2
0.37
64
376
(3021589) Normoblasts [#/volume] in Blood
173
1327
1.70
4.91
12.1
10.9
e9/l
0.0
0.0
0.50
153
1032
(3024471) HLA-A [Type]
12
28
4.42
4.87
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
12
28
4.42
4.87
1.0
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
30
128
2.49
4.75
1.3
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
116
807
1.71
4.67
1.6
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
26
105
2.61
4.60
2.0
1.4
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
10
21
4.89
4.56
6.6
2.8
mmol/l
7.4
6.3
—
10
21
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
21
4.89
4.56
2.6
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
104
709
1.71
4.48
3.9
4.2
e6/l
20.5
41.1
0.92
85
530
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
111
772
1.69
4.43
4.3
4.3
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
11
26
4.35
4.39
6.1
2.5
mmol/l
1.4
1.2
0.41
11
26
(3017181) Myelocytes/100 leukocytes in Blood
34
160
2.27
4.35
3.5
5.8
%
0.2
0.7
—
10
52
(3051651) Icteric interference index of Serum or Plasma
12
31
3.99
4.30
1.8
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
31
141
2.33
4.29
3.1
5.5
%
0.0
0.5
—
7
33
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
29
128
2.40
4.28
2.6
2.0
u/ml
98.4
102.3
—
5
10
(3021440) Promyelocytes/100 leukocytes in Blood
32
148
2.30
4.26
3.4
6.1
%
0.0
0.2
—
10
46
(1175426) CD3 cells/100 lymphocytes in Blood
17
58
3.05
4.08
2.1
3.6
%
50.5
66.0
1.68
17
58
(3009871) Measles virus Ab [Titer] in Serum
7
7
10.20
4.03
1.1
2.0
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
9
14
6.59
4.01
1.1
1.6
umol/l
12.8
10.7
—
9
14
(3000850) Epithelial cells [#/volume] in Urine
73
464
1.75
3.98
3.6
3.2
e6/l
4.8
7.4
0.74
65
402
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
270
2418
2.04
3.85
14.0
9.0
u/l
27.5
27.4
0.01
263
2334
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
28
128
2.31
3.84
2.6
2.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
96
664
1.65
3.82
3.9
4.1
e6/l
0.3
0.3
0.16
80
484
(36304419) Bacteria [Presence] in Urine
96
666
1.65
3.77
3.8
4.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
10
25
4.10
3.73
2.9
1.6
e6/l
13218.0
7811.5
—
10
17
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
28
130
2.27
3.71
2.6
2.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
45
3.21
3.70
4.8
4.2
%
59.4
50.5
1.20
14
45
(4306422)
13
40
3.35
3.67
1.3
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
46
262
1.89
3.56
5.1
3.2
g/l
9.2
9.3
0.03
46
253
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
27
126
2.25
3.54
3.1
2.8
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
8
13
6.29
3.52
3.3
2.5
mmol/l
4.1
3.9
—
8
13
(3035285) Chloride [Moles/volume] in Venous blood
8
13
6.29
3.52
3.3
2.5
mmol/l
107.5
105.8
—
8
13
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
8
13
6.29
3.52
1.3
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
13
6.29
3.52
3.3
2.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
88
607
1.63
3.51
3.1
3.1
mmol/l
2.4
2.4
0.43
83
555
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
272
2463
1.99
3.44
24.6
11.3
mg/l
26.8
21.9
1.55
229
1734
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
21
89
2.46
3.40
2.2
2.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
65
418
1.71
3.37
2.5
3.8
e6/l
3.5
2.0
0.50
40
238
(3025159) Blasts/100 leukocytes in Blood
29
144
2.12
3.28
3.5
6.2
%
0.0
0.0
—
8
39
(3021788) Differential panel - Synovial fluid
8
15
5.45
3.21
2.1
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
18
73
2.56
3.19
9.6
6.5
%
49.1
56.4
0.61
18
73
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
44
3.04
3.17
1.5
1.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
14
50
2.89
3.13
1.2
1.2
u/ml
3.9
3.8
—
7
24
(3023520) Reticulocytes [#/volume] in Blood
39
221
1.88
3.08
4.6
5.0
e9/l
70.8
65.9
0.25
31
148
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
45
2.97
3.06
5.0
4.1
e9/l
4.3
3.2
0.78
13
45
(3018418) pH of Serum or Plasma
73
496
1.62
3.05
6.3
3.5
ph
7.4
7.4
0.21
16
93
(3009542) Hematocrit [Volume Fraction] of Blood
275
2522
1.95
3.00
32.9
14.0
%
39.5
40.1
0.86
248
2194
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
22
103
2.22
2.88
3.4
2.4
ml/min/173m2
53.6
82.8
—
7
42
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
31
3.30
2.80
1.5
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
49
2.73
2.66
1.3
1.1
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
5
7
7.24
2.56
1.8
3.4
%
23.4
8.3
—
5
7
(21494814) CD8 cells/100 lymphocytes in Specimen
5
7
7.24
2.56
1.8
3.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
207
1798
1.47
2.53
4.8
3.6
pmol/l
15.6
14.5
6.19
191
1664
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
61
418
1.57
2.44
2.8
3.7
e6/l
1.2
0.6
0.72
39
239
(3034426) Prothrombin time (PT)
6
12
5.08
2.41
1.0
1.2
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
13
52
2.57
2.39
2.0
3.6
%
15.3
25.2
2.50
13
52
(3002619) Bacteria identified in Specimen by Culture
5
8
6.33
2.38
1.0
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
22
3.71
2.38
2.4
2.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
28
3.28
2.32
1.6
1.8
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
72
2.29
2.32
10.9
13.2
—
2129.3
—
0
12
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
53
2.52
2.31
2.3
2.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
18
3.95
2.26
3.0
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
14
62
2.32
2.11
1.4
1.5
ug/g
232.7
324.4
—
6
34
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
26
147
1.84
2.10
1.7
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
20
3.56
2.06
1.1
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
20
3.56
2.06
1.1
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
20
3.56
2.06
1.1
1.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
32
2.87
2.01
6.0
5.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
71
524
1.46
2.01
2.8
2.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
38
244
1.64
1.99
1.5
1.5
pmol/l
485.5
30876048.3
0.50
33
217
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
11
4.60
1.95
2.2
1.6
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
5
11
4.60
1.95
1.8
3.2
e9/l
0.6
0.1
—
5
11
(3011897) Casein IgE Ab [Units/volume] in Serum
0
50
0.00
1.90
0.0
1.7
—
3.4
—
0
14
(3004588) Protein electrophoresis panel - Serum or Plasma
12
52
2.36
1.90
1.1
3.0
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
13
59
2.26
1.87
2.2
3.9
%
34.8
16.5
1.64
13
59
(3020393) Adenovirus Ag [Presence] in Stool
10
40
2.55
1.85
1.2
2.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
17
3.58
1.84
4.5
4.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
63
463
1.45
1.82
1.6
1.8
mmol/l
1.3
1.4
0.45
58
411
(3037467) Urinalysis macro (dipstick) panel - Urine
172
1497
1.34
1.76
4.9
4.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
13
61
2.18
1.74
2.1
2.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
48
2.34
1.72
1.3
1.3
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
5
13
3.89
1.72
1.4
1.8
ug/l
4.2
5.3
—
5
13
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
55
2.23
1.69
1.8
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
10
42
2.43
1.69
3.5
3.3
%
15.7
17.3
—
5
24
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
17
90
1.94
1.69
1.6
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
31
2.62
1.67
3.9
2.6
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
19
3.20
1.67
9.2
8.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
19
3.20
1.67
2.7
1.6
pg
31.8
33.2
—
6
19
(3011985) Renin [Units/volume] in Plasma
6
19
3.20
1.67
2.3
1.3
mu/l
454.8
632.8
—
6
14
(3027944) Amphetamines [Presence] in Urine
15
273
0.53
1.66
1.9
1.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
217
2349
0.73
1.61
4.4
3.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
12
57
2.15
1.57
2.2
2.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
193
1725
1.33
1.56
3.8
3.1
mmol/l
1.2
1.2
0.93
183
1617
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
10
44
2.32
1.55
1.8
1.8
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
33
2.46
1.55
1.1
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
16
278
0.55
1.53
2.0
1.9
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
27
2.63
1.52
1.1
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
69
534
1.38
1.49
7.1
5.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
16
276
0.56
1.49
1.9
1.9
—
—
—
0
0
(4034850)
9
37
2.48
1.49
5.3
5.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
228
2095
1.35
1.48
5.4
4.0
mu/l
2.1
1.9
1.97
218
1960
(3013290) Carbon dioxide [Partial pressure] in Blood
9
38
2.41
1.47
5.4
4.5
kpa
4.7
5.0
—
9
38
(3027315) Oxygen [Partial pressure] in Blood
9
38
2.41
1.47
5.4
4.5
kpa
7.9
9.4
—
9
38
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
73
1.96
1.46
1.1
2.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
16
274
0.56
1.46
1.9
1.9
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
22
2.76
1.44
1.2
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
177
1576
1.29
1.41
4.4
4.0
mmol/mol
36.1
37.8
1.81
168
1492
(3035637) Corticotropin [Mass/volume] in Plasma
17
97
1.80
1.38
1.5
1.8
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
23
2.64
1.37
1.0
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
74
914
0.75
1.36
1.5
1.7
u/ml
0.8
3.0
2.62
19
167
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
17
2.97
1.36
1.2
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
146
0.47
1.36
1.0
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
37
0.00
1.35
0.0
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
12
61
2.01
1.34
8.5
11.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
10
192
0.50
1.33
2.5
2.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
17
278
0.59
1.32
1.2
1.3
—
—
—
0
0
(3010421) pH of Blood
9
43
2.13
1.31
5.4
4.2
ph
7.4
7.4
—
9
38
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
24
2.53
1.31
6.7
11.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
84
687
1.31
1.26
2.0
1.8
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
23
148
1.60
1.24
3.0
2.0
u/ml
187.2
165.4
0.17
16
70
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
16
259
0.60
1.20
1.2
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
16
258
0.60
1.19
1.8
1.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
199
1821
1.27
1.17
4.1
3.3
mmol/l
4.2
4.6
5.05
192
1715
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
137
0.50
1.12
1.6
2.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
41
1.98
1.09
2.5
2.0
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
5
21
2.40
1.09
8.4
6.9
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
5
21
2.40
1.09
6.4
6.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
52
1.95
1.07
1.2
1.5
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
12
67
1.82
1.06
1.5
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
12
67
1.82
1.06
2.4
1.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
29
205
1.46
1.05
2.1
2.4
u/l
27.9
33.4
0.38
23
173
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
9
46
1.99
1.04
1.8
2.7
—
572.1
—
0
7
(1616796) Gas panel - Central venous blood
9
46
1.99
1.04
6.2
4.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
34
2.08
1.03
1.3
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
38
498
0.73
1.03
2.5
3.4
ug/g
212.7
103.5
0.36
33
395
(40761535) Cells panel - Urine sediment
18
115
1.60
1.02
5.3
3.8
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
22
148
1.52
1.01
3.0
2.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
51
637
0.76
1.00
1.9
2.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
29
0.00
0.98
0.0
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
12
70
1.74
0.94
1.3
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
196
1817
1.22
0.90
4.3
3.4
mmol/l
2.6
2.8
1.73
186
1700
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
71
1.72
0.90
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
71
1.72
0.90
1.5
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
14
216
0.63
0.89
2.0
2.0
—
—
—
0
0
(4062490)
8
43
1.88
0.88
1.4
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
194
1801
1.21
0.86
4.0
3.3
mmol/l
1.3
1.4
3.62
184
1687
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
48
592
0.78
0.86
1.8
2.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
31
1.95
0.85
1.0
2.0
g/l
3.1
3.1
—
6
26
(3008898) HLA-B27 [Presence]
9
150
0.59
0.81
1.1
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
32
244
1.35
0.79
1.3
1.3
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
2.1
—
3.1
—
0
19
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
33
1.83
0.79
1.0
1.9
g/l
6.6
7.6
—
6
28
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
33
1.83
0.79
1.0
1.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
33
1.83
0.79
1.0
1.9
g/l
3.0
3.8
—
6
26
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
26
0.00
0.79
0.0
1.5
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
27
0.00
0.78
0.0
22.7
—
1528.1
—
0
27
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
27
0.00
0.78
0.0
13.6
—
749.9
—
0
27
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
28
0.00
0.76
0.0
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
10
160
0.61
0.76
1.3
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
50
411
1.26
0.73
1.6
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
39
481
0.78
0.71
5.1
2.9
kg/l
1.0
1.0
—
5
76
(3003888) Timothy IgE Ab [Units/volume] in Serum
12
180
0.65
0.70
1.1
1.2
u/ml
10.3
6.9
—
7
141
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
16
224
0.70
0.67
1.4
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
78
1.56
0.66
1.3
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
28
1.80
0.66
1.6
2.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
17
120
1.44
0.66
1.0
1.1
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
7
44
1.60
0.65
1.0
1.0
g/l
162.1
162.3
—
7
44
(3008401) Mugwort IgE Ab [Units/volume] in Serum
12
177
0.66
0.65
1.0
1.2
u/ml
3.2
1.4
—
7
131
(3019832) Treponema pallidum Ab [Presence] in Serum
39
475
0.79
0.64
1.7
1.8
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
5
29
1.74
0.64
1.8
4.6
%
0.2
1.4
—
5
22
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
164
0.66
0.63
1.3
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
18
130
1.41
0.63
1.0
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
14
197
0.70
0.61
1.1
1.3
u/ml
26.5
2.7
—
9
130
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.3
—
19.4
—
0
7
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.3
—
24.2
—
0
5
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
21
0.00
0.60
0.0
2.7
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
8.5
—
0.6
—
0
21
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
21
0.00
0.60
0.0
5.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
89
991
0.86
0.58
1.8
1.9
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
6
36
1.68
0.57
5.0
4.1
umol/l
24.8
28.5
—
6
36
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
36
1.68
0.57
1.8
1.8
—
—
—
0
0
(1002224) Polysomnography panel
5
89
0.55
0.57
1.0
1.1
—
—
—
0
0
(3020891) Body temperature
8
55
1.47
0.56
11.4
6.7
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
6
37
1.63
0.56
5.0
3.2
mg/l
15.3
26.5
—
6
26
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
37
1.63
0.56
1.0
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
6
37
1.63
0.56
1.0
1.1
%
97.0
77.1
—
6
37
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
103
934
1.16
0.55
4.3
3.3
nmol/l
73.2
71.3
0.28
97
873
(3028707) Methadone [Presence] in Urine by Screen method
9
132
0.67
0.53
2.3
2.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
40
335
1.22
0.52
3.3
3.4
mg/l
210.6
120.6
0.49
24
238
(3021879) Hepatitis B virus core Ab [Presence] in Serum
29
234
1.26
0.52
1.4
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
171
1613
1.14
0.50
6.7
4.3
mm/h
7.9
8.4
0.23
165
1495
(3037522) Nuclear Ab [Titer] in Serum
38
318
1.22
0.50
1.4
1.4
titre
391.1
369.6
—
9
50
(36660697) Celiac disease serology panel - Serum
33
395
0.82
0.48
1.3
1.2
—
—
—
0
0
(4035726)
19
147
1.31
0.46
3.8
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
10
69
1.46
0.45
4.0
2.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
54
612
0.86
0.44
1.8
1.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
31
1.62
0.43
2.0
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
58
650
0.87
0.41
2.5
2.2
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.2
—
28.6
—
0
15
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.1
—
37.3
—
0
15
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
8
59
1.37
0.41
3.6
3.5
u/ml
20.6
26.6
—
8
54
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
6.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
16
0.00
0.41
0.0
2.3
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
7
103
0.67
0.40
1.0
1.0
kpa
2.9
3.3
—
7
89
(3006598) pH of Arterial cord blood
7
104
0.67
0.40
1.0
1.0
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
7
104
0.67
0.40
1.0
1.0
kpa
7.4
7.2
—
7
90
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
7
104
0.67
0.40
1.0
1.0
mmol/l
21.1
19.4
—
7
104
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
5
35
1.44
0.39
2.8
6.0
mmol/l
6.3
6.4
—
5
29
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.9
—
18.7
—
0
6
(3029634) Reagin Ab [Titer] in Serum by VDRL
9
66
1.37
0.38
1.3
1.6
—
—
—
0
0
(4198724)
5
36
1.40
0.38
2.0
1.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
36
1.40
0.38
1.8
1.9
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
69
1.31
0.37
1.2
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
12
157
0.75
0.36
1.3
1.2
—
18.4
—
0
6
(3020682) Albumin/Creatinine [Ratio] in Urine
39
340
1.17
0.35
4.4
4.1
mg/mmol
35.1
14.7
0.78
24
235
(3035350) Ketones [Presence] in Urine by Test strip
111
1041
1.10
0.33
4.0
3.3
estimate
0.0
0.0
0.00
21
188
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
46
1.31
0.33
1.2
5.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
25
294
0.84
0.32
1.4
1.9
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
10
74
1.36
0.32
2.0
1.9
u/l
39.6
38.5
—
10
69
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
182
1751
1.10
0.32
3.4
3.0
mmol/l
5.5
5.6
0.50
173
1614
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
27
231
1.19
0.31
2.1
2.3
mmol/l
2.4
2.4
0.36
22
197
(3045462) Protein/Creatinine [Ratio] in Urine
7
53
1.33
0.31
1.9
7.5
g/mol
43.6
94.7
—
7
46
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
53
1.33
0.31
1.7
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
84
1.32
0.30
1.2
2.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
14
173
0.80
0.29
2.4
2.2
—
5.7
—
0
6
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
162
0.79
0.29
1.2
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
59
540
1.11
0.28
3.8
3.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
116
0.77
0.28
1.7
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
18
150
1.21
0.27
8.4
5.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
57
523
1.11
0.26
4.8
3.4
estimate
0.0
0.0
0.50
20
194
(3009508) Creatinine [Moles/volume] in Urine
65
605
1.09
0.23
3.4
4.2
mmol/l
6.0
8.2
3.48
59
550
(46235355) HIV 1 and 2 tests - Meaningful Use set
71
757
0.92
0.22
2.0
2.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
41
1.22
0.22
1.2
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
110
1050
1.07
0.22
4.0
3.3
estimate
0.0
0.0
0.00
22
190
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
1.2
—
0
6
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.7
—
85.7
—
0
11
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(4024509)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
10
0.00
0.21
0.0
8.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
4.5
—
107.9
—
0
10
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
1465.0
—
0
10
(40758292) HTLV I+II Ab panel - Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
20.1
—
0
13
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
17.2
—
0
7
(3023511) Choriogonadotropin [Units/volume] in Urine
10
122
0.81
0.19
1.8
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
24
213
1.14
0.19
1.4
1.3
iu/ml
267.9
136.0
—
9
67
(3021601) Nitrite [Presence] in Urine by Test strip
109
1045
1.07
0.19
5.4
4.8
estimate
0.0
0.0
0.00
22
200
(42870560) Thyrotropin [Units/volume] in Cord blood
10
121
0.82
0.18
1.0
1.0
mu/l
8.0
8.7
—
10
107
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
11
91
1.22
0.18
1.5
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
71
748
0.93
0.17
4.7
3.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
12
141
0.84
0.16
2.2
2.4
ug/l
0.3
0.8
—
5
78
(40761536) Microorganisms panel - Urine sediment
21
188
1.13
0.15
4.7
3.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
81
1.11
0.15
1.9
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
82
1.10
0.15
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
89
0.78
0.14
1.1
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
97
0.82
0.14
2.1
1.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
100
0.79
0.14
1.1
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
29
314
0.92
0.13
1.2
1.2
u/ml
27.4
8.4
—
10
113
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
10
117
0.85
0.13
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
10
117
0.85
0.13
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
10
117
0.85
0.13
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
10
117
0.85
0.13
1.3
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
17
187
0.90
0.10
3.9
2.1
iu/l
8.0
12.7
0.60
17
140
(3019225) pH of Specimen
14
125
1.13
0.10
7.9
5.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
5
45
1.11
0.10
2.2
1.5
u/l
6.2
13.6
—
5
37
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
46
1.09
0.09
1.6
1.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
5
46
1.09
0.09
4.4
6.3
ug/l
3.4
2.1
—
5
46
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
19
206
0.92
0.09
1.5
2.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
28
263
1.07
0.08
2.7
1.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
66
1.06
0.08
1.1
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
7
67
1.05
0.08
1.0
1.1
—
3.6
—
0
9
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
34
323
1.06
0.08
1.4
1.2
iu/ml
16.4
30.6
—
9
90
(3022145) Colonoscopy Study observation
16
174
0.92
0.08
1.2
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
75
1.07
0.07
1.9
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
84
1.07
0.07
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
9
86
1.05
0.07
1.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
34
356
0.95
0.07
1.5
2.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
54
558
0.96
0.07
1.6
1.6
pmol/l
86.8
98.7
1.32
32
284
(3047352) Trisomy 18 risk [Likelihood] in Fetus
8
95
0.84
0.06
1.4
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
8
95
0.84
0.06
1.4
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
35
335
1.05
0.06
1.4
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
129
1.09
0.05
1.4
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
12
130
0.92
0.04
1.3
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
17
180
0.94
0.04
1.9
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
147
1456
1.02
0.03
4.8
3.9
u/l
52.5
34.5
2.37
139
1406
(3007164) IgA [Mass/volume] in Serum or Plasma
85
863
0.98
0.03
1.8
1.6
g/l
1.8
1.8
0.17
63
460
(3003327) Ova and parasites identified in Stool by Light microscopy
14
148
0.94
0.02
1.9
1.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
16
167
0.96
0.01
3.4
3.4
%
31.6
31.4
0.03
11
112
(3041096) Erythrocytes [Presence] in Urine by Automated
55
558
0.98
0.01
3.7
2.8
—
—
—
0
0
(4010399)
13
124
1.05
0.00
1.6
1.4
—
—
—
0
0
(3000492) Spirometry study
23
236
0.97
0.00
1.5
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
14
142
0.99
0.00
1.4
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
60
599
1.00
0.00
1.7
1.7
—
—
—
0
0
(3015736) pH of Urine
85
849
1.00
0.00
4.1
3.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
103
0.97
0.00
1.2
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
11
107
1.03
0.00
1.8
1.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
21
206
1.02
0.00
1.6
2.5
u/l
20622.2
3716.0
—
5
77
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
24
236
1.02
0.00
1.3
1.5
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
5
53
0.94
0.00
3.2
2.2
nmol/l
0.2
0.1
—
5
44
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
94
0.96
0.00
1.3
1.1
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
17.2
—
0
5
(3009410) PHENobarbital [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
8.0
—
109.4
—
0
7
(3017569) Oxygen content in Arterial blood
0
5
0.00
0.00
0.0
15.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
64
0.94
0.00
1.3
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(4038314)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
5
0.00
0.00
0.0
3.0
—
6.4
—
0
5
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
16.6
—
0
8
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
71.9
—
0
6
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.0
—
47.0
—
0
5
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
6.8
—
3.9
—
0
6
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
0
6
0.00
0.00
0.0
2.7
—
1.7
—
0
6
(21494890) Protein electrophoresis panel - 24 hour Urine
0
8
0.00
0.00
0.0
4.9
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.8
—
133.3
—
0
9
(3002523) Influenza virus A Ag [Presence] in Specimen
9
94
0.96
0.00
1.3
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
9
98
0.92
0.00
1.3
1.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
8
79
1.01
0.00
1.6
1.8
nmol/l
1.8
0.5
—
8
68
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
52
0.96
0.00
1.2
1.4
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
5
0.00
0.00
0.0
1.8
—
399.2
—
0
5
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
13.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
9
0.00
0.00
0.0
2.8
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
6
0.00
0.00
0.0
9.7
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_RVOTO and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_RVOTO | 3.515 [2.39, 5.18] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.018 |
During the follow-up period (1.1.1998 — 31.12.2019), 64 out of 1741 females with Q17_RVOTO died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_RVOTO | 3.988 [2.8, 5.67] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.067 |
During the follow-up period (1.1.1998 — 31.12.2019), 78 out of 1456 males with Q17_RVOTO died.
Mortality risk
Mortality risk for people of age
years, who have Q17_RVOTO.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.277% | 1.065% |
| 5 | 1.604% | 5.562% |
| 10 | 3.891% | 12.841% |
| 15 | 7.539% | 22.479% |
| 20 | 12.735% | 35.979% |
Relationships between endpoints
↥Index endpoint: Q17_RVOTO – Right ventricular outflow tract obstruction
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data